HRT Financial’s BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share BOAS.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,153
Closed -$5K 3808
2022
Q3
$5K Hold
23,153
﹤0.01% 2601
2022
Q2
$3K Hold
23,153
﹤0.01% 2794
2022
Q1
$6K Hold
23,153
﹤0.01% 2950
2021
Q4
$12K Buy
+23,153
New +$14.2K ﹤0.01% 3011

HRT Financial's BOAS.WS Position: Q4 2022 in Review

HRT Financial sold out of BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share (BOAS.WS) in Q4 2022, closing a stake of 23,153 shares — an estimated $5K sold.

HRT Financial first reported a position in BOAS.WS in Q4 2021 and held it in 4 quarters. The position peaked at $12K in Q4 2021. 0 funds tracked by Wall St. Rank hold BOAS.WS as of Q4 2022.

  • HRT Financial reported no remaining BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 23,153 BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share shares in Q4 2022, an estimated $5K.
  • HRT Financial first reported a position in BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share in Q4 2021 and held it in 4 quarters.
  • HRT Financial's BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share position peaked at $12K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.